Reviews

Research progress on the application effect of IABP in acute myocardial infarction and the management of thrombosis

  • Yuxuan ZHOU ,
  • Jian YANG ,
  • Jing ZHANG ,
  • Jun. YANG
Expand
  • Vasculocardiology Department,the First Clinical Medical School of China Three Gorges University,Yichang Central People's Hospital,Yichang 443003,China

Received date: 2023-11-15

  Online published: 2024-07-15

Abstract

Acute myocardial infarction has the characteristics of rapid progression, dangerous condition, unstable hemodynamics, and is prone to thrombosis, resulting in a high clinical mortality rate. Intra-aortic balloon counterpulsation (IABP) has the function of increasing intra-aortic diastolic pressure, reducing left ventricular afterload, and enhancing coronary artery blood supply. It is a common auxiliary and transitional treatment method for coronary intervention, which can significantly improve the safety and clinical efficacy of coronary intervention. Therefore, it is widely used in high-risk and complex coronary heart disease, mainly acute myocardial infarction. This article reviews the research progress on the application effect and thrombosis management of IABP in acute myocardial infarction in recent years.

Cite this article

Yuxuan ZHOU , Jian YANG , Jing ZHANG , Jun. YANG . Research progress on the application effect of IABP in acute myocardial infarction and the management of thrombosis[J]. The Journal of Practical Medicine, 0 : 2031 -2034 . DOI: 10.3969/j.issn.1006-5725.2024.14.022

References

1 DAMLUJI A A, VAN DIEPEN S, KATZ J N, et al Mechanical Complications of Acute Myocardial Infarction : A Scientific Statement From the American Heart Association[J]. Circulation, 2021,144(2):e16-e35. doi:10.1161/cir.0000000000000985
2 SAITO Y, OYAMA K, TSUJITA K, et al. Treatment strategies of acute myocardial infarction: updates on revascularization, pharmacological therapy, and beyond[J]. J Cardiol,2023,81(2):168-178. doi:10.1016/j.jjcc.2022.07.003
3 MEYERS H P, BRACEY A, LEE D, et al. Comparison of the ST-Elevation Myocardial Infarction (STEMI) vs. NSTEMI and Occlusion MI (OMI) vs. NOMI Paradigms of Acute MI[J]. J Emerg Med,2021,60(3):273-284. doi:10.1016/j.jemermed.2020.10.026
4 孙天保,贺莹,高鹏燕,等. IABP联合急诊PCI术对急性心肌梗死后心源性休克患者平均动脉压、乳酸水平的影响[J]. 川北医学院学报, 2020,35(3):417-419. doi:10.3969/j.issn.1005-3697.2020.03.015
5 郭超,杨昊翰,王心宇,等. 主动脉内球囊反搏置入时机对急性心肌梗死合并心原性休克患者预后的影响[J]. 中国循环杂志, 2022,37(8):782-788. doi:10.3969/j.issn.1000-3614.2022.08.004
6 IMAMURA T, JURICEK C, NGUYEN A, et al. Predictors of Hemodynamic Improvement and Stabilization Following Intraaortic Balloon Pump Implantation in Patients With Advanced Heart Failure[J]. J Invasive Cardiol, 2018,30(2): 56-61.
7 孔祥勇,陈鸿武,余晓凡,等. 主动脉内球囊反搏对暴发性心肌炎引起难治性心源性休克患者的临床疗效[J]. 中国临床保健杂志, 2019,22(5):584-587. doi:10.3969/J.issn.1672-6790.2019.05.003
8 马贵洲,徐荣和,周琳洁,等. 急性前壁心肌梗死患者急诊经皮冠脉介入术后主动脉内球囊反搏与重组人脑利钠肽对心功能的保护作用[J]. 实用医学杂志,2022,38(21):2720-2726. doi:10.3969/j.issn.1006-5725.2022.21.016
9 陈慧敏,赵冬,石春来. IABP对老年心血管危重症病人心功能及血流动力学的影响[J]. 中西医结合心脑血管病杂志,2019,17(22):3634-3636. doi:10.12102/j.issn.1672-1349.2019.22.050
10 KARAMI M, ERIKSEN E, OUWENEEL D M, et al. Long-term 5-year outcome of the randomized IMPRESS in severe shock trial: percutaneous mechanical circulatory support vs. intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction[J]. Eur Heart J Acute Cardiovasc Care,2021,10(9):1009-1015. doi:10.1093/ehjacc/zuab020.210
11 DHRUVA S S, ROSS J S, MORTAZAVI B J, et al. Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock[J]. JAMA,2020,323(8):734-745. doi:10.1001/jama.2020.0254
12 罗晓亮,张峻,袁建松,等. 主动脉内球囊反搏在急性心肌梗死合并室间隔穿孔患者中的临床应用及并发症情况分析[J]. 中国分子心脏病学杂志,2019,19(6):3131-3134.
13 李琴,檀鑫,姜文溪,等. 急性心肌梗死患者经皮冠状动脉介入治疗后远期主要不良心血管事件预测模型的构建[J]. 中国全科医学,2022,25(24):2965-2974. doi:10.12114/j.issn.1007-9572.2022.0237
14 陈兰涛,吴田田,陈敬,等. 主动脉内球囊反搏联合左西孟旦治疗急性心肌梗死心源性休克患者的临床疗效观察[J]. 中国中西医结合急救杂志, 2022,29(5):529-534. doi:10.3969/j.issn.1008-9691.2022.05.004
15 CHEN Z, GAO Y, LIN Y. Perspectives and Considerations of IABP in the Era of ECMO for Cardiogenic Shock[J]. Adv Ther, 2023,40(10):4151-4165. doi:10.1007/s12325-023-02598-8
16 韩宗茂,高洁,高传玉,等. 早期血运重建及体外膜肺氧合支持治疗急性心肌梗死合并心原性休克的疗效观察及影响因素分析[J]. 中国循环杂志, 2021,36(5):433-438. doi:10.3969/j.issn.1000-3614.2021.05.004
17 邱承杰,陈玉善,解金红,等. 体外膜肺氧合联合主动脉内球囊反搏对急性心肌梗死合并心原性休克患者直接经皮冠状动脉介入治疗临床预后的影响[J]. 中国心血管杂志, 2021,26(3):257-261. doi:10.3969/j.issn.1007-5410.2021.03.011
18 张慧霞,张超红. 主动脉球囊反搏联合急诊PCI对急性心肌梗死合并心源性休克病人术后血清cTnI、 NSE、 PCT水平及生存质量的影响[J]. 中西医结合心脑血管病杂志,2019,17(5):748-751. doi:10.12102/j.issn.1672-1349.2019.05.028
19 赵国敏,边伟帅,陈炜. 主动脉球囊反搏术对脓毒症休克合并低心排血量患者心脏指数、动脉血乳酸水平及短期预后的影响[J]. 广西医学,2023,45(12):1414-1417.
20 蔡庆慧,郭长英,陈红卫,等. 主动脉内球囊反搏不同应用时机的疗效研究[J]. 心肺血管病杂志,2021,40(6):592-596. doi:10.3969/j.issn.1007-5062.2021.06.015
21 史坚,张静波,邢震宇,等. 非体外循环冠状动脉旁路移植术围术期应用IABP病人血糖变异水平与并发症发生风险的关系[J]. 中西医结合心脑血管病杂志,2021,19(17):2986-2989. doi:10.12102/j.issn.1672-1349.2021.17.024
22 杜林翔,王娜. IABP辅助PCI治疗老年ACS合并心力衰竭患者的疗效分析[J]. 临床心血管病杂志,2020,36(4):352-354.
23 李丹,胡昊,吴佳纬,等. IABP辅助经皮冠状动脉介入治疗高危冠心病患者的危险因素[J]. 中国老年学杂志,2021,41(6):1121-1124. doi:10.3969/j.issn.1005-9202.2021.06.001
24 桑梓楠,张凤伟,高宗炜. 静脉-静脉转流的体外膜肺氧合模式联合主动脉内球囊反搏术抢救多支冠状动脉完全闭塞合并急性重症肺水肿一例报道[J]. 实用心脑肺血管病杂志, 2020,28(9):134-137. doi:10.3969/j.issn.1008-5971.2020.09.027
25 崔晓娜,冯瑞霞,韩雨澎,等. 静脉-动脉体外膜肺氧合和主动脉内球囊反搏联合辅助顺序对急性心肌梗死合并心源性休克患者的临床效果比较研究[J]. 中国全科医学, 2023,26(35):4439-4445. doi:10.12114/j.issn.1007-9572.2023.0248
26 张威,程云涛,谭咏梅,等. Impella与IABP治疗急性心肌梗死致心源性休克的临床观察[J]. 中华生物医学工程杂志,2019,25(3):356-359. doi:10. 3760/cma. j. issn. 1674?1927. 2019. 03. 018
27 魏金刚,王素星,刘振中,等. 红花黄色素预防重症破伤风下肢静脉血栓形成的效果[J]. 实用医学杂志,2019,35(22):3527-3530. doi:10.3969/j.issn.1006-5725.2019.22.021
28 王鹏,赵玉洁,任杰. 利伐沙班、华法林对急性心肌梗死合并左心室血栓患者的疗效观察[J]. 血栓与止血学,2022,28(3):774-775. doi:10.3969/j.issn.1009-6213.2022.03.190
29 SHAH A, ONWUMBIKO B, ENCARNACION C O, et al. Implantation of Left Ventricular Assist Device After Descending Aortic Stent Graft for Mural Thrombus[J]. Heart Surg Forum,2020,23(1):E007-E009. doi:10.1532/hsf.2675
30 NDAO S C T, AMARA W BEN, ZABALAWI A, et al. Dissection coronaire spontanée dans le SCA ST+ chez un homme jeune : échec de fibrinolyse [Spontaneous coronary artery dissection in young male patient with STEMI: Unsuccessful fibrinolysis][J]. Ann Cardiol Angeiol (Paris),2021,70(1):47-50. doi:10.1016/j.ancard.2020.03.011
31 WOLLER S C, STEVENA S M, KAPLAN D, et al. Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial[J]. Blood Adv, 2022,6(6):1661-1670. doi:10.1182/bloodadvances.2021005808
32 DE VRIESE A S, CALUWE R, VAN DER MEERSCH H, et al. Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial[J]. J Am Soc Nephrol,2021,32(6):1474-1483. doi:10.1681/asn.2020111566
33 胡彦,马仰,张剑平. 下腔静脉滤器置入联合溶栓与利伐沙班治疗下肢深静脉血栓临床效果[J]. 皖南医学院学报,2023,42(4):351-354. doi:10.3969/j.issn.1002-0217.2023.04.012
Outlines

/